Many frequent replacement contact lens wearers 'stretch' prescribed replacement intervals

Article

The majority of patients wearing frequent replacement contact lenses are not compliant with their prescribed replacement schedule.

Key Points

Johnson & Johnson Vision Care sponsored the survey. However, the participants were randomly selected from a panel of U.S. consumers who volunteered to take part in online surveys about a variety of products and were unaware that the information in this survey was being sought by a contact lens manufacturer.

A total of 448 consumers wearing hydrogel contact lenses and 197 consumers with silicone hydrogel contact lenses provided answers to a series of questions about replacement frequency.

Minor stretching was identified among 65% of persons in the 2-week replacement group and 55% of those in the 4-week replacement group (p = 0.02), whereas 4% of patients in the 2-week group and 23% of those in the 4-week/monthly group displayed extreme stretching (waiting ≥8 weeks) to replace their lenses (p <0.01).

"There continues to be debate in the industry about the optimum replacement schedule for soft contact lenses," said Sheila B. Hickson-Curran, BSc (Hons), MCOptom, FAAO, Director of Medical Affairs, VISTAKON, Division of Johnson & Johnson Vision Care Inc.

Taking sides

"While there is good science to suggest that more frequent replacement is better for optical performance, patient comfort, and ocular health, there are advocates for a longer replacement interval based on the idea that reduced frequency of replacement would improve replacement compliance," Hickson-Curran said.

"The results of this survey reaffirm that noncompliance with prescriber's instructions is an important issue among contact lens wearers," she continued. "They are also consistent with the old adage, 'Give 'em an inch and they'll take a mile.' It's counterintuitive that patients who are noncompliant with a 2-week replacement schedule will be more adherent to instructions if allowed to wait 4 weeks to change lenses.

"Furthermore, noncompliance with a 4-week replacement schedule may put patients on a slippery slope leading to significant problems," Hickson-Curran said.

"Therefore, when noncompliance with frequent replacement is an issue, switching to single-use lenses is probably a better alternative because there are good data to show that vision, comfort, and safety are best with these products that avoid the need for cleaning/disinfection solutions, storage cases, and remembering about replacement."

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.